Beat the Burn: The First Topical Gel for EGFR-Induced Rashes

Researchers at UCLA Health Jonsson Comprehensive Cancer Center and MD Anderson Cancer Center have unveiled a breakthrough topical gel, LUT014, that significantly alleviates the painful acne-like rash induced by anti-EGFR cancer therapies for colorectal cancer patients. This innovative gel works by paradoxically reactivating the MAPK pathway in the skin—counteracting the shutdown caused by EGFR inhibitors—thereby […]